Department of Nutritional and Physiological Chemistry, University of Vienna, Vienna, Austria.
Chair of Food Chemistry and Molecular Sensory Science, Technische Universität München, Freising, Germany.
J Nutr Biochem. 2014 Jul;25(7):750-7. doi: 10.1016/j.jnutbio.2014.03.002. Epub 2014 Mar 22.
Pyridines are widely distributed in foods. Nicotinic acid (NA), a carboxylated pyridine derivative, inhibits lipolysis in adipocytes by activation of the orphan NA receptor (HM74A) and is applied to treat hyperlipidemia. However, knowledge on the impact of pyridine derivatives on intestinal lipid metabolism is scarce. This study was performed to identify the structural determinants of pyridines for their effects on fatty acid uptake in enterocyte-like Caco-2 cells and to elucidate the mechanisms of action. The impact of 17 pyridine derivatives on fatty acid uptake was tested. Multiple regression analysis revealed the presence of a methyl group to be the structural determinant at 0.1 mM, whereas at 1 mM, the presence of a carboxylic group and the N-methylation presented further structural characteristics to affect the fatty acid uptake. NA, showing a stimulating effect on FA uptake, and N-methyl-4-phenylpyridinium (MPP), inhibiting FA uptake, were selected for mechanistic studies. Gene expression of the fatty acid transporters CD36, FATP2 and FATP4, and the lipid metabolism regulating transcription factors peroxisome proliferator-activated receptor (PPAR) α and PPARγ was up-regulated upon NA treatment. Caco-2 cells were demonstrated to express the low-affinity NA receptor HM74 of which the gene expression was up-regulated upon NA treatment. We hypothesize that the NA-induced fatty acid uptake might result from NA receptor activation and related intracellular signaling cascades. In contrast, MPP increased transepithelial electrical resistance. We therefore conclude that NA and MPP, both sharing the pyridine motif core, exhibit their contrary effects on intestinal FA uptake by activation of different mechanisms.
吡啶广泛存在于食物中。烟碱酸(NA),一种羧酸化吡啶衍生物,通过激活孤儿 NA 受体(HM74A)抑制脂肪细胞的脂肪分解,用于治疗高血脂症。然而,关于吡啶衍生物对肠道脂质代谢影响的知识还很缺乏。本研究旨在确定吡啶衍生物影响肠上皮细胞样 Caco-2 细胞脂肪酸摄取的结构决定因素,并阐明其作用机制。测试了 17 种吡啶衍生物对脂肪酸摄取的影响。多元回归分析显示,在 0.1mM 时,存在甲基是结构决定因素,而在 1mM 时,存在羧酸基团和 N-甲基化则进一步呈现出影响脂肪酸摄取的结构特征。NA 对 FA 摄取有刺激作用,而 N-甲基-4-苯基吡啶(MPP)抑制 FA 摄取,被选为机制研究的候选物。脂肪酸转运蛋白 CD36、FATP2 和 FATP4 的基因表达以及脂质代谢调节转录因子过氧化物酶体增殖物激活受体(PPAR)α和 PPARγ的基因表达在 NA 处理后上调。Caco-2 细胞表达低亲和力 NA 受体 HM74,其基因表达在 NA 处理后上调。我们假设,NA 诱导的脂肪酸摄取可能是由于 NA 受体激活和相关的细胞内信号级联反应所致。相反,MPP 增加了跨上皮电阻。因此,我们得出结论,NA 和 MPP 都具有吡啶基核心,通过激活不同的机制,对肠道 FA 摄取表现出相反的作用。